Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $2.09 Million - $2.28 Million
-7,300 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $76,037 - $107,601
339 Added 4.87%
7,300 $2.23 Million
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $1.77 Million - $2.48 Million
-8,039 Reduced 53.59%
6,961 $1.62 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $4.34 Million - $4.89 Million
15,000 New
15,000 $4.7 Million
Q4 2017

Feb 13, 2018

SELL
$216.94 - $271.3 $3.25 Million - $4.07 Million
-15,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $3.18 Million - $3.63 Million
15,000
15,000 $3.33 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lombard Odier Asset Management (Usa) Corp Portfolio

Follow Lombard Odier Asset Management (Usa) Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.